tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
BCRX is currently covered by 10 analysts with an average price target of $20.25. This is a potential upside of $12.6 (164.71%) from yesterday's end of day stock price of $7.65.
BioCryst Pharmaceuticals's activity chart (see below) currently has 229 price targets and 199 ratings on display. The stock rating distribution of BCRX is 85.71% BUY and 14.29% HOLD.
Analysts average stock forecasts to be materialized ratio is 47.09% with an average time for these price targets to be met of 279.53 days.
Highest price target for BCRX is $32, Lowest price target is $9, average price target is $20.25.
Most recent stock forecast was given by JESSICA FYE from JPMORGAN on 30-Sep-2026. First documented stock forecast 28-Aug-2013.
Currently out of the existing stock ratings of BCRX, 18 are a BUY (85.71%), 3 are a HOLD (14.29%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 13-Jul-2026
$13
$5.35 (69.93%)
$12
25 days ago
(30-Sep-2026)
6/9 (66.67%)
$4.67 (56.06%)
234
Buy Since 25-Sep-2023
$11
$3.35 (43.79%)
$14
1 months 15 days ago
(10-Sep-2026)
28/35 (80%)
$2.71 (32.69%)
353
Buy Since 20-Apr-2023
$16
$8.35 (109.15%)
$16
1 months 17 days ago
(08-Sep-2026)
5/20 (25%)
$6.93 (76.41%)
334
Buy Since 30-Jun-2025
$20
$12.35 (161.44%)
$21
2 months 19 days ago
(06-Aug-2026)
0/5 (0%)
$10.7 (115.05%)
Buy Since 03-Nov-2023
$17
$9.35 (122.22%)
$15
3 months 25 days ago
(30-Jun-2026)
9/12 (75%)
$7 (70.00%)
344
What is BCRX (BioCryst Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on BCRX (BioCryst Pharmaceuticals)?
Which analyst has the most public recommendations on BCRX (BioCryst Pharmaceuticals)?
Which analyst is the currently most bullish on BCRX (BioCryst Pharmaceuticals)?
Which analyst is the currently most reserved on BCRX (BioCryst Pharmaceuticals)?
